WPC
TXG icon

Wedmont Private Capital’s 10x Genomics TXG Stock Holding History

Wedmont Private Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$715K Sell
9,254
-890
-9% -$52.1K 0.02% 487
2026
Q2 		$433K Sell
10,144
-902
-8% -$23.6K 0.01% 601
2026
Q1 		$254K Buy
+11,046
New +$221K 0.01% 723

Other funds holding TXG

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Wedmont Private Capital's TXG Position: Q3 2026 in Review

Wedmont Private Capital reduced its 10x Genomics (TXG) stake by 8.8% in Q3 2026, selling an estimated $52.1K and leaving 9,254 shares worth $715K. The position accounts for 0.02% of the portfolio, ranked #487.

Wedmont Private Capital first reported a position in TXG in Q1 2026 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Wedmont Private Capital held 9,254 shares of 10x Genomics worth $715K as of Q3 2026.
  • Wedmont Private Capital sold 890 10x Genomics shares in Q3 2026, an estimated $52.1K.
  • 10x Genomics made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #487 holding.
  • Wedmont Private Capital first reported a position in 10x Genomics in Q1 2026 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.